JP2022512714A5 - - Google Patents

Info

Publication number
JP2022512714A5
JP2022512714A5 JP2021520962A JP2021520962A JP2022512714A5 JP 2022512714 A5 JP2022512714 A5 JP 2022512714A5 JP 2021520962 A JP2021520962 A JP 2021520962A JP 2021520962 A JP2021520962 A JP 2021520962A JP 2022512714 A5 JP2022512714 A5 JP 2022512714A5
Authority
JP
Japan
Prior art keywords
kit according
region
connection region
molecule
con
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021520962A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512714A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/056831 external-priority patent/WO2020081875A1/en
Publication of JP2022512714A publication Critical patent/JP2022512714A/ja
Publication of JP2022512714A5 publication Critical patent/JP2022512714A5/ja
Pending legal-status Critical Current

Links

JP2021520962A 2018-10-18 2019-10-17 プロト抗原提示合成表面、活性化t細胞及びそれらの使用 Pending JP2022512714A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862747569P 2018-10-18 2018-10-18
US62/747,569 2018-10-18
PCT/US2019/056831 WO2020081875A1 (en) 2018-10-18 2019-10-17 Proto-antigen-presenting synthetic surfaces, activated t cells, and uses thereof

Publications (2)

Publication Number Publication Date
JP2022512714A JP2022512714A (ja) 2022-02-07
JP2022512714A5 true JP2022512714A5 (https=) 2022-10-20

Family

ID=70284828

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021520962A Pending JP2022512714A (ja) 2018-10-18 2019-10-17 プロト抗原提示合成表面、活性化t細胞及びそれらの使用

Country Status (10)

Country Link
US (2) US20200139362A1 (https=)
EP (1) EP3867353A4 (https=)
JP (1) JP2022512714A (https=)
KR (1) KR20210078526A (https=)
CN (1) CN113272417A (https=)
AU (1) AU2019362009A1 (https=)
CA (1) CA3115531A1 (https=)
IL (1) IL282320A (https=)
SG (1) SG11202103296RA (https=)
WO (1) WO2020081875A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018226900A2 (en) 2017-06-06 2018-12-13 Zymergen Inc. A htp genomic engineering platform for improving fungal strains
WO2019236848A1 (en) 2018-06-06 2019-12-12 Zymergen Inc. Manipulation of genes involved in signal transduction to control fungal morphology during fermentation and production
AU2020385015A1 (en) 2019-11-17 2022-06-09 Berkeley Lights, Inc. Systems and methods for analyses of biological samples
US11479779B2 (en) 2020-07-31 2022-10-25 Zymergen Inc. Systems and methods for high-throughput automated strain generation for non-sporulating fungi
WO2022125874A2 (en) * 2020-12-11 2022-06-16 Berkeley Lights, Inc. Methods for identification of exchangeable mhc binding peptides and methods of use thereof
WO2023161961A1 (en) * 2022-02-24 2023-08-31 Lymphon Biologics Pvt. Ltd. A system and method for t cell activation and immunomodulation

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690915A (en) 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans
US5827642A (en) 1994-08-31 1998-10-27 Fred Hutchinson Cancer Research Center Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
US6787154B2 (en) * 1998-10-20 2004-09-07 Salvatore Albani Artificial antigen presenting cells
US6294063B1 (en) 1999-02-12 2001-09-25 Board Of Regents, The University Of Texas System Method and apparatus for programmable fluidic processing
US6942776B2 (en) 1999-05-18 2005-09-13 Silicon Biosystems S.R.L. Method and apparatus for the manipulation of particles by means of dielectrophoresis
US7601270B1 (en) 1999-06-28 2009-10-13 California Institute Of Technology Microfabricated elastomeric valve and pump systems
US20030170238A1 (en) 2002-03-07 2003-09-11 Gruenberg Micheal L. Re-activated T-cells for adoptive immunotherapy
US6958132B2 (en) 2002-05-31 2005-10-25 The Regents Of The University Of California Systems and methods for optical actuation of microfluidics based on opto-electrowetting
US20040248205A1 (en) * 2003-04-16 2004-12-09 Stern Lawrence J. Major histocompatibility complex (MHC)-peptide arrays
WO2005100541A2 (en) 2004-04-12 2005-10-27 The Regents Of The University Of California Optoelectronic tweezers for microparticle and cell manipulation
EP1814580B1 (en) 2004-11-24 2016-08-10 Fred Hutchinson Cancer Research Center Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens
WO2008091848A2 (en) 2007-01-22 2008-07-31 Advanced Liquid Logic, Inc. Surface assisted fluid loading and droplet dispensing
WO2008119066A1 (en) 2007-03-28 2008-10-02 The Regents Of The University Of California Single-sided lateral-field and phototransistor-based optoelectronic tweezers
WO2009045308A2 (en) 2007-10-03 2009-04-09 Fred Hutchinson Cancer Research Center Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression
EP2569633B1 (en) 2010-05-14 2016-02-10 The General Hospital Corporation Compositions and methods of identifying tumor specific neoantigens
US9533306B2 (en) 2010-08-02 2017-01-03 The Regents Of The University Of California Single sided continuous optoelectrowetting (SCEOW) device for droplet manipulation with light patterns
ITRM20110248A1 (it) * 2011-05-20 2012-11-21 Univ Roma Method to prognose viral infection by measuring t cell response or auto-antibodies to apoptotic epitopes
US9227200B2 (en) 2011-06-03 2016-01-05 The Regents Of The University Of California Microfluidic devices with flexible optically transparent electrodes
US10758487B2 (en) * 2011-12-09 2020-09-01 The Johns Hopkins University Artificial antigen presenting cells having a defined and dynamic shape
US10386367B2 (en) 2012-01-04 2019-08-20 Jacobs University Bremen Ggmbh Method for producing an examination reagent and kit for analysing a T-cell frequency
US9857333B2 (en) 2012-10-31 2018-01-02 Berkeley Lights, Inc. Pens for biological micro-objects
US9403172B2 (en) 2012-11-08 2016-08-02 Berkeley Lights, Inc. Circuit based optoelectronic tweezers
KR102164405B1 (ko) * 2013-03-14 2020-10-12 더 존스 홉킨스 유니버시티 나노스케일 인공 항원 제시 세포
KR102257305B1 (ko) 2013-03-28 2021-05-28 더 유니버시티 오브 브리티쉬 콜롬비아 미세유동 장치 및 분비물의 다세포 검정법에서의 그의 사용 방법
US9889445B2 (en) 2013-10-22 2018-02-13 Berkeley Lights, Inc. Micro-fluidic devices for assaying biological activity
EP3760703A1 (en) 2013-10-22 2021-01-06 Berkeley Lights, Inc. Microfluidic devices having isolation pens and methods of testing biological micro-objects with same
US20150306599A1 (en) 2014-04-25 2015-10-29 Berkeley Lights, Inc. Providing DEP Manipulation Devices And Controllable Electrowetting Devices In The Same Microfluidic Apparatus
EP3134739B1 (en) 2014-04-25 2019-07-10 Berkeley Lights, Inc. Providing dep manipulation devices and controllable electrowetting devices in the same microfluidic apparatus
US20150306598A1 (en) 2014-04-25 2015-10-29 Berkeley Lights, Inc. DEP Force Control And Electrowetting Control In Different Sections Of The Same Microfluidic Apparatus
EP3194967A1 (en) * 2014-09-16 2017-07-26 Università degli Studi di Roma "La Sapienza" Method and kit for the predictive prognosis of responsiveness to treatments of autoimmune diseases
ES2905615T3 (es) * 2014-11-20 2022-04-11 Promega Corp Sistemas y métodos para evaluar moduladores de puntos de control inmunitario
US10520251B2 (en) 2015-01-15 2019-12-31 Heraeus Noblelight America Llc UV light curing systems, and methods of designing and operating the same
JP6752231B2 (ja) * 2015-06-01 2020-09-09 カリフォルニア インスティテュート オブ テクノロジー 抗原を用いて特異的集団に関してt細胞をスクリーニングするための組成物および方法
US11059880B2 (en) * 2015-06-30 2021-07-13 Arizona Board Of Regents On Behalf Of The University Of Arizona Redirected cells with MHC chimeric receptors and methods of use in immunotherapy
US12071663B2 (en) 2016-01-15 2024-08-27 Massachusetts Institute Of Technology Semi-permeable arrays for analyzing biological systems and methods of using same
CN109196094A (zh) * 2016-03-17 2019-01-11 伯克利之光生命科技公司 微流体装置中t淋巴细胞的选择和克隆
EP3455630A4 (en) * 2016-05-13 2020-01-08 MBL International Corp. PEPTIDE EXCHANGE SYSTEM AND METHOD
CN115678773A (zh) 2016-05-26 2023-02-03 伯克利之光生命科技公司 共价修饰的表面、试剂盒及制备方法和用途

Similar Documents

Publication Publication Date Title
JP2022512714A5 (https=)
JP2022065174A5 (https=)
JP7417432B2 (ja) 新規リンカー、その製造方法およびその応用
BAY et al. Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. A possible approach to a synthetic carbohydrate vaccine
TWI440468B (zh) 經由樹突狀細胞凝集素樣氧化型低密度脂蛋白受體-1(lox-1)之人類抗原呈現細胞活化
JP7427286B2 (ja) IL-2RβγC結合化合物
JP2020182458A5 (https=)
JP2024056696A (ja) 二重il-2rおよびil-7r結合化合物
JP2023514128A (ja) IL-7Rαγc結合化合物
JP2021528434A (ja) インテグリンαvβ3に結合するためのペプチドリガンド
CA3169452A1 (en) Il-7r.alpha. binding compounds
JP2021528431A (ja) Il−17に結合するためのペプチドリガンド
JPH07502026A (ja) ウイルス抗体複合体
JPH0259128B2 (https=)
WO2021080008A1 (ja) 1価ccap生成物の製造方法
EP1844072B1 (en) Mhc oligomer and method of making the same
US6676946B2 (en) Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof
Viswamitra et al. Structure of TANDEM and its implication for bifunctional intercalation into DNA
CN117447557B (zh) 一种靶向cldn4蛋白的多肽及其制备方法和应用
WO2023196876A1 (en) Il-7ralpha-gamma ligand immunoglobulin fusion proteins
WO2024100451A3 (en) Compositions and uses of tumor activated antibodies targeting egfr and effector cell antigens
JP2022528053A5 (https=)
Haas et al. Bispecific antibodies increase T-cell stimulatory capacity in vitro of human autologous virus-modified tumor vaccine.
JPH06500077A (ja) 接合体物質、試薬および新規なポリエーテル
EP2635585A1 (en) High-efficiency catalysts, preparation and use thereof